메뉴 건너뛰기




Volumn 66, Issue 11, 2011, Pages 2615-2623

'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing

Author keywords

Drug resistance; HIV 1 RT mutations; Minority variants; UDPS

Indexed keywords

ANTIVIRUS AGENT; RNA DIRECTED DNA POLYMERASE; THYMIDINE;

EID: 80054705708     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr354     Document Type: Article
Times cited : (16)

References (32)
  • 1
    • 0028286025 scopus 로고
    • Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease
    • Kaplan AH, Michael SF, Wehbie RS et al. Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease. Proc Natl Acad Sci USA 1994; 91: 5597-601.
    • (1994) Proc Natl Acad Sci USA , vol.91 , pp. 5597-5601
    • Kaplan, A.H.1    Michael, S.F.2    Wehbie, R.S.3
  • 2
    • 34848844088 scopus 로고    scopus 로고
    • Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study
    • Costagliola D, Descamps D, Assoumou L et al. Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study. J Acquir Immune Defic Syndr 2007; 46: 12-8.
    • (2007) J Acquir Immune Defic Syndr , vol.46 , pp. 12-18
    • Costagliola, D.1    Descamps, D.2    Assoumou, L.3
  • 3
    • 3142660152 scopus 로고    scopus 로고
    • The prevalence of antiretroviral drug resistance in the United States
    • Richman DD, Morton SC, Wrin T et al. The prevalence of antiretroviral drug resistance in the United States. AIDS 2004; 18: 1393-401.
    • (2004) AIDS , vol.18 , pp. 1393-1401
    • Richman, D.D.1    Morton, S.C.2    Wrin, T.3
  • 4
    • 46349112103 scopus 로고    scopus 로고
    • Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel
    • Hirsch MS, Günthard HF, Schapiro JM et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis 2008; 47: 266-85.
    • (2008) Clin Infect Dis , vol.47 , pp. 266-285
    • Hirsch, M.S.1    Günthard, H.F.2    Schapiro, J.M.3
  • 5
    • 84855616052 scopus 로고    scopus 로고
    • Panel on Antiretroviral Guidelines for Adults and Adolescents, Department of Health and Human Services. (24 May 2011, date last accessed)
    • Panel on Antiretroviral Guidelines for Adults and Adolescents, Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. 2011; 1-166. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (24 May 2011, date last accessed).
    • (2011) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents , pp. 1-166
  • 6
    • 0037043652 scopus 로고    scopus 로고
    • Antiretroviral-drug resistance among patients recently infected with HIV
    • Little SJ, Holte S, Routy JP et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002; 347: 385-94.
    • (2002) N Engl J Med , vol.347 , pp. 385-394
    • Little, S.J.1    Holte, S.2    Routy, J.P.3
  • 7
    • 40949107410 scopus 로고    scopus 로고
    • Preexisting resistance to non nucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naïve HIV-1 infected subjects
    • Kuritzkes DR, Lalama CM, Ribaudo HJ et al. Preexisting resistance to non nucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naïve HIV-1 infected subjects. J Infect Dis 2008; 197: 867-70.
    • (2008) J Infect Dis , vol.197 , pp. 867-870
    • Kuritzkes, D.R.1    Lalama, C.M.2    Ribaudo, H.J.3
  • 8
    • 79955477986 scopus 로고    scopus 로고
    • Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study
    • Wittkop L, Günthard HF, de Wolf F et al. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis 2011; 11: 363-71.
    • (2011) Lancet Infect Dis , vol.11 , pp. 363-371
    • Wittkop, L.1    Günthard, H.F.2    de Wolf, F.3
  • 10
    • 76449101531 scopus 로고    scopus 로고
    • Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure
    • Paredes R, Lalama CM, Ribaudo HJ et al. Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. J Infect Dis 2010; 201: 662-71.
    • (2010) J Infect Dis , vol.201 , pp. 662-671
    • Paredes, R.1    Lalama, C.M.2    Ribaudo, H.J.3
  • 11
    • 76449107778 scopus 로고    scopus 로고
    • Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment-experienced patients
    • Halvas EK, Wiegand A, Boltz VF et al. Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment-experienced patients. J Infect Dis 2010; 201: 672-80.
    • (2010) J Infect Dis , vol.201 , pp. 672-680
    • Halvas, E.K.1    Wiegand, A.2    Boltz, V.F.3
  • 13
    • 77955690396 scopus 로고    scopus 로고
    • Minority variants of drug-resistant HIV
    • Gianella S, Richman DD. Minority variants of drug-resistant HIV. J Infect Dis 2010; 202: 657-66.
    • (2010) J Infect Dis , vol.202 , pp. 657-666
    • Gianella, S.1    Richman, D.D.2
  • 14
    • 61849172898 scopus 로고    scopus 로고
    • Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naïve patients significantly impact treatment outcomes
    • Simen BB, Simons JF, Hullsiek KH et al. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naïve patients significantly impact treatment outcomes. J Infect Dis 2009; 199: 693-701.
    • (2009) J Infect Dis , vol.199 , pp. 693-701
    • Simen, B.B.1    Simons, J.F.2    Hullsiek, K.H.3
  • 15
    • 70350534553 scopus 로고    scopus 로고
    • Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors
    • Varghese V, Shahriar R, Rhee SY et al. Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr 2009; 52: 309-15.
    • (2009) J Acquir Immune Defic Syndr , vol.52 , pp. 309-315
    • Varghese, V.1    Shahriar, R.2    Rhee, S.Y.3
  • 16
    • 79952267805 scopus 로고    scopus 로고
    • Update of the drug resistance mutations in HIV-1: December 2010
    • Johnson VA, Brun-Vézinet F, Clotet B et al. Update of the drug resistance mutations in HIV-1: December 2010. Top HIV Med 2010; 18: 156-63.
    • (2010) Top HIV Med , vol.18 , pp. 156-163
    • Johnson, V.A.1    Brun-Vézinet, F.2    Clotet, B.3
  • 17
    • 17444388859 scopus 로고    scopus 로고
    • Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors
    • Harrigan PR, Mo T, Wynhoven B et al. Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors. AIDS 2005; 19: 549-54.
    • (2005) AIDS , vol.19 , pp. 549-554
    • Harrigan, P.R.1    Mo, T.2    Wynhoven, B.3
  • 18
    • 33746216625 scopus 로고    scopus 로고
    • Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptase
    • Berkhout B, Backa NKT, de Rondea A et al. Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptase. AIDS 2006; 20: 1515-20.
    • (2006) AIDS , vol.20 , pp. 1515-1520
    • Berkhout, B.1    Backa, N.K.T.2    de Rondea, A.3
  • 19
    • 62749200513 scopus 로고    scopus 로고
    • Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
    • Bennett DE, Camacho RJ, Otelea D et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One 2009; 4: e4724.
    • (2009) PLoS One , vol.4
    • Bennett, D.E.1    Camacho, R.J.2    Otelea, D.3
  • 20
    • 4143099182 scopus 로고    scopus 로고
    • Identification of the minimal conserved structure of HIV-1 protease in the presence or absence of drug pressure
    • Ceccherini-Silberstein F, Erba F, Gago F et al. Identification of the minimal conserved structure of HIV-1 protease in the presence or absence of drug pressure. AIDS 2004; 18: 11-9.
    • (2004) AIDS , vol.18 , pp. 11-19
    • Ceccherini-Silberstein, F.1    Erba, F.2    Gago, F.3
  • 21
    • 78650637852 scopus 로고    scopus 로고
    • on behalf of the 454 HIV Alpha Study Group A multicenter collaborative study on HIV drug resistance testing using 454 massively parallel pyrosequencing
    • Simen BB, Braverman MS, Abbate I et al. on behalf of the 454 HIV Alpha Study Group. A multicenter collaborative study on HIV drug resistance testing using 454 massively parallel pyrosequencing. Antiviral Ther 2010; 15 Suppl 2: A37.
    • (2010) Antiviral Ther , vol.15 , Issue.SUPPL 2
    • Simen, B.B.1    Braverman, M.S.2    Abbate, I.3
  • 22
    • 77955199812 scopus 로고    scopus 로고
    • Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study
    • Lataillade M, Chiarella J, Yang R et al. Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study. PLoS One 2010; 3: 5.
    • (2010) PLoS One , vol.3 , pp. 5
    • Lataillade, M.1    Chiarella, J.2    Yang, R.3
  • 23
    • 34547643929 scopus 로고    scopus 로고
    • Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance
    • Wang C, Mitsuya Y, Gharizadeh B et al. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res 2007; 17: 1195-201.
    • (2007) Genome Res , vol.17 , pp. 1195-1201
    • Wang, C.1    Mitsuya, Y.2    Gharizadeh, B.3
  • 24
    • 77954192930 scopus 로고    scopus 로고
    • Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution
    • Johnson JA, Geretti AM. Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution. J Antimicrob Chemother 2010; 65: 1322-6.
    • (2010) J Antimicrob Chemother , vol.65 , pp. 1322-1326
    • Johnson, J.A.1    Geretti, A.M.2
  • 25
    • 79955002593 scopus 로고    scopus 로고
    • Selection and co-evolution of mutational patterns in the HIV-1 integrase characterized by pyrosequencing analysis
    • Ceccherini-Silberstein F, Armenia D, D'Arrigo R et al. Selection and co-evolution of mutational patterns in the HIV-1 integrase characterized by pyrosequencing analysis. Antiviral Ther 2009; 14 Suppl 1: A125.
    • (2009) Antiviral Ther , vol.14 , Issue.SUPPL. 1
    • Ceccherini-Silberstein, F.1    Armenia, D.2    D'Arrigo, R.3
  • 26
    • 48749086685 scopus 로고    scopus 로고
    • Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy
    • Johnson JA, Li JF, Wei X et al. Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy. PLoS Med 2008; 5: e158.
    • (2008) PLoS Med , vol.5
    • Johnson, J.A.1    Li, J.F.2    Wei, X.3
  • 27
    • 58749087348 scopus 로고    scopus 로고
    • Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatmentnaïve and -adherent patients
    • Metzner JK, Giulieri SG, Knoepfe SA et al. Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatmentnaïve and -adherent patients. Clin Infect Dis 2009; 48: 239-47.
    • (2009) Clin Infect Dis , vol.48 , pp. 239-247
    • Metzner, J.K.1    Giulieri, S.G.2    Knoepfe, S.A.3
  • 28
    • 49849095346 scopus 로고    scopus 로고
    • Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy
    • Peuchant O, Thiébaut R, Capdepont S et al. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy. AIDS 2008; 22: 1417-23.
    • (2008) AIDS , vol.22 , pp. 1417-1423
    • Peuchant, O.1    Thiébaut, R.2    Capdepont, S.3
  • 29
    • 80054690981 scopus 로고    scopus 로고
    • Complex patterns of drug-resistance mutations in newly-diagnosed HIV-infected patients: implications with the transmission of resistant strains
    • Alteri C, Svicher V, Gori C et al. Complex patterns of drug-resistance mutations in newly-diagnosed HIV-infected patients: implications with the transmission of resistant strains. BMC Infect Dis 2009; 1: 11.
    • (2009) BMC Infect Dis , vol.1 , pp. 11
    • Alteri, C.1    Svicher, V.2    Gori, C.3
  • 30
    • 41449090659 scopus 로고    scopus 로고
    • Transmission of drug-resistant HIV-1 in Europe remains limited to single classes
    • SPREAD programme
    • SPREAD programme. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS 2008; 22: 625-35.
    • (2008) AIDS , vol.22 , pp. 625-635
  • 31
    • 24644472997 scopus 로고    scopus 로고
    • Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
    • Wensing AM, van de Vijver DA, Angarano G et al. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis 2005; 192: 958-66.
    • (2005) J Infect Dis , vol.192 , pp. 958-966
    • Wensing, A.M.1    van de Vijver, D.A.2    Angarano, G.3
  • 32
    • 70449723682 scopus 로고    scopus 로고
    • Transmission of drug-resistant HIV-1 is stabilizing in Europe
    • Vercauteren J, Wensing AM, van de Vijver DA et al. Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis 2009; 200: 1503-8.
    • (2009) J Infect Dis , vol.200 , pp. 1503-1508
    • Vercauteren, J.1    Wensing, A.M.2    van de Vijver, D.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.